These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2363714)

  • 1. Differential inhibition of protein kinase C subtypes.
    Pelosin JM; Keramidas M; Souvignet C; Chambaz EM
    Biochem Biophys Res Commun; 1990 Jun; 169(3):1040-8. PubMed ID: 2363714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of [3H]staurosporine binding in protein kinase C-II purified from rat brain.
    Miyazaki A; Kitamura Y; Nomura Y
    Neurochem Int; 1993 May; 22(5):455-64. PubMed ID: 8485451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intrinsic ATPase activity of protein kinase C is catalyzed at the active site of the enzyme.
    Ward NE; O'Brian CA
    Biochemistry; 1992 Jun; 31(25):5905-11. PubMed ID: 1535219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate-dependent inhibition of protein kinase C by specific inhibitors.
    Junco M; Díaz-Guerra MJ; Boscá L
    FEBS Lett; 1990 Apr; 263(1):169-71. PubMed ID: 2332048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential sensitivity of protein kinase C isozymes to phospholipid-induced inactivation.
    Huang KP; Huang FL
    J Biol Chem; 1990 Jan; 265(2):738-44. PubMed ID: 2295617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C. Differential activation and inhibition of protein kinase C isozymes.
    Mahoney CW; Azzi A; Huang KP
    J Biol Chem; 1990 Apr; 265(10):5424-8. PubMed ID: 1690710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chelerythrine is a potent and specific inhibitor of protein kinase C.
    Herbert JM; Augereau JM; Gleye J; Maffrand JP
    Biochem Biophys Res Commun; 1990 Nov; 172(3):993-9. PubMed ID: 2244923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H7-resistant protein kinase C substrates in two-dimensional gels of proestrous rat anterior pituitary gland.
    Simpson J; Johnson MS; Mitchell R
    Biochim Biophys Acta; 1993 Dec; 1220(1):69-75. PubMed ID: 8268247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of protein kinase C by myristate and its requirements of Ca2+ and phospholipid.
    Iwata M; Edashige K; Saeki K
    Physiol Chem Phys Med NMR; 1990; 22(4):211-8. PubMed ID: 2101933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C.
    Loomis CR; Bell RM
    J Biol Chem; 1988 Feb; 263(4):1682-92. PubMed ID: 3338987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spermine protects protein kinase C from phospholipid-induced inactivation.
    Monti MG; Marverti G; Ghiaroni S; Piccinini G; Pernecco L; Moruzzi MS
    Experientia; 1994 Oct; 50(10):953-7. PubMed ID: 7957772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of protein kinase C inhibits ATP-induced [Ca2+]i elevation in rat osteoblastic cells: selective effects on P2Y and P2U signaling pathways.
    Gallinaro BJ; Reimer WJ; Dixon SJ
    J Cell Physiol; 1995 Mar; 162(3):305-14. PubMed ID: 7860638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C and vascular smooth muscle contractility: effects of inhibitors and down-regulation.
    Merkel LA; Rivera LM; Colussi DJ; Perrone MH
    J Pharmacol Exp Ther; 1991 Apr; 257(1):134-40. PubMed ID: 2019982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinase that relaxes vascular smooth muscle.
    Robinson PJ; Cheng HC; Black CK; Schmidt CJ; Kariya T; Jones WD; Dage RC
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1392-8. PubMed ID: 2175806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of H7-resistant protein kinase C isoforms from gonadotroph-derived alpha T3-1 cells.
    Simpson J; Johnson MS; Clegg RA; Mitchell R
    Biochem Biophys Res Commun; 1996 Jan; 218(3):720-5. PubMed ID: 8579580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of protein kinase C activators and inhibitors on membrane properties, synaptic responses, and cholinergic actions in CA1 subfield of rat hippocampus in situ and in vitro.
    Agopyan N; Agopyan I
    Synapse; 1991 Mar; 7(3):193-206. PubMed ID: 1882329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of angiotensin II binding sites in neuronal cultures by protein kinase C.
    Kalberg CJ; Sumners C
    Am J Physiol; 1990 Apr; 258(4 Pt 1):C610-7. PubMed ID: 2333947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
    Steele TA; Brahmi Z
    J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells.
    Müller HK; Kellerer M; Ermel B; Mühlhöfer A; Obermaier-Kusser B; Vogt B; Häring HU
    Diabetes; 1991 Nov; 40(11):1440-8. PubMed ID: 1657668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates.
    Ward NE; O'Brian CA
    Mol Pharmacol; 1992 Feb; 41(2):387-92. PubMed ID: 1538715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.